Endoluminal Suturing Devices Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The endoluminal suturing devices market encompasses tools designed to perform suturing during endoscopic or transluminal procedures without requiring external incisions. Valued at around $545 million globally in 2025, the market serves a critical role in minimally invasive surgery by enabling internal wound closure and tissue approximation. The devices are primarily used in bariatric and gastrointestinal surgical applications, with hospitals accounting for the dominant share of end-use.

• •Market valued at $545.03 million in 2025
• •Primary applications in bariatric and gastrointestinal surgery
• •Hospitals represent the main end-use segment

The market is influenced by several interconnected factors, most notably the global rise in obesity prevalence, which drives increasing demand for bariatric surgical interventions. Growing adoption of minimally invasive surgical techniques over traditional open procedures has expanded the use of endoscopic suturing solutions in clinical practice. Additionally, clinical evidence supporting the efficacy of endoluminal suturing and ongoing product innovations continue to support market expansion.

• •Rising global obesity rates increase bariatric procedure volumes
• •Growing preference for minimally invasive surgical approaches
• •Continuous product innovation improving device efficacy and ease of use

The market is segmented by application into bariatric surgery and gastrointestinal surgery, with bariatric procedures representing the larger segment due to widespread adoption of weight-loss interventions. End-use segmentation shows hospitals as the primary channel, though ambulatory surgical centers and specialty clinics account for smaller shares. Geographically, North America currently leads the market, supported by advanced healthcare infrastructure and high procedure volumes, while Asia-Pacific shows notable growth potential.

• •Bariatric surgery is the leading application segment
• •Hospitals dominate end-use distribution
• •North America leads in regional market share

What are the recent trends and outlook?

The market is expected to maintain modest growth trajectories through the forecast period, supported by incremental improvements in device design and expanding clinical indications. Integration of advanced materials and enhanced articulation mechanisms represents a key area of product development focus. As healthcare systems continue emphasizing minimally invasive options, demand for endoluminal suturing devices is likely to remain stable across core application areas.

• •Steady growth expected through 2030-2032
• •Focus on improved device maneuverability and materials
• •Expanding clinical applications driving sustained demand